PDS Biotechnology (PDSB) Other Accumulated Expenses (2014 - 2026)
PDS Biotechnology's Other Accumulated Expenses was $896,894 in Q2 2026, down 9.2% from $988,101 a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at PDS Biotechnology came in at $271,742, down 59.0% from FY2024.
- Other Accumulated Expenses has now declined for three consecutive years, with a five-year compound annual growth rate of -27.0% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $663,399 in FY2024 (-48.6%), $1.29 million in FY2023 (-29.8%), $1.84 million in FY2022 (+26.0%) and $1.46 million in FY2021 (+11.3%).
- Quarterly Other Accumulated Expenses has moved between $271,742 (Q4 2025) and $1.84 million (Q4 2022) over five years.
- Compared with a year earlier, Other Accumulated Expenses was higher in three of the last seven quarters, with an average decline of 12.9%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q3 2023 (growth of 50.0%); the worst was Q4 2025 (a decline of 59.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 896,894.00 |
| Dec 31, 2025 | 271,742.00 |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 988,101.00 |
| Mar 31, 2025 | 552,447.00 |
| Dec 31, 2024 | 663,399.00 |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 892,894.00 |
| Mar 31, 2024 | 418,449.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 782,075.00 |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 732,842.00 |
| Dec 31, 2021 | 1.46 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 1.03 Mn |
API Access
PDS Biotechnology Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();